This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Esocap Ag, Universität Greifswald. Active years: 2020-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2025
Title: Kirsten Kirsch: Innovator in Pharmaceutical Dosage Forms
Introduction
Kirsten Kirsch is a notable inventor based in Greifswald, Germany. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative dosage forms for mucous membranes. With a total of 2 patents, her work is recognized for its potential to enhance drug delivery systems.
Latest Patents
Kirsten Kirsch's latest patents focus on pharmaceutical dosage forms designed for application to mucous membranes. These inventions include a sheet-like preparation, which can be film-shaped, foil-shaped, or wafer-shaped, containing an active pharmaceutical ingredient. The unique aspect of her inventions is the incorporation of a release mechanism and a trigger mechanism. This trigger mechanism is specifically designed to activate the release of the preparation at predetermined sites within the gastrointestinal tract, rectum, or vagina, thereby improving the efficacy of drug delivery.
Career Highlights
Throughout her career, Kirsten has worked with esteemed organizations such as Esocap AG and Universität Greifswald. Her experience in these institutions has allowed her to develop her expertise in pharmaceutical formulations and drug delivery systems.
Collaborations
Kirsten has collaborated with notable colleagues, including Mirko Koziolek and Werner Weitschies. These partnerships have contributed to her innovative research and development efforts in the pharmaceutical field.
Conclusion
Kirsten Kirsch stands out as a pioneering inventor in the realm of pharmaceutical dosage forms. Her contributions are poised to make a significant impact on drug delivery methods, enhancing patient care and treatment outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile